Nexgel(NASDAQ) NXGLW

Market CapN/A

Since IPO (2021)-98%

5 YearN/A

1 Year-94%

1 Month+18%

$0.02

+6.51%

+0.00Today

Nexgel last closing stock price
Metric	Price	Date
Last close	USD 0.02	2026-08-31

Nexgel stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+57.89%	USD 0.01	2026-08-24
1 month	+18.42%	USD 0.02	2026-07-31
3 month	-55.11%	USD 0.04	2026-06-02
Year to date	-92.34%	USD 0.24	2025-12-31
1 year	-94%	USD 0.30	2025-08-29
3 year	-95.38%	USD 0.39	2023-09-01
Since inception	-97.7%	USD 0.78	2021-12-22

Nexgel Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$12.07M

Net Income (TTM)

-$6.19M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.02

Volume

Open

$0.02

Price

$0.02

Volume

Open

$0.02

Previous Close

$0.02

Daily Range

$0.01 - $0.02

52-Week Range

$0.01 - $0.34

Estimated Earnings Date

Nov 17, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.02

Volume

Open

$0.02

Previous Close

$0.02

Daily Range

$0.01 - $0.02

52-Week Range

$0.01 - $0.34

Estimated Earnings Date

Nov 17, 2026

NXGLW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nexgel

NEXGEL, Inc. is a specialized manufacturer of advanced hydrogels and gels, known for their high water content and unique properties. The company serves various sectors, including wound care, medical diagnostics, and cosmetic applications.

Products and Services

Hydrogels for wound care and transdermal drug delivery
Cosmetic products like facial masks and under-eye patches
Foot care solutions, including blister shields and cracked heel patches

Growth Outlook

Revenue increased to $3.686 million in Q2 2026, up from $2.650 million in Q1 2026
Gross profit margin improved to 30.09% in Q2 2026 from 40.04% in Q1 2026
Strong demand for innovative hydrogel products supports future growth potential

Financial Highlights

Net income of -$3.637 million reported in Q2 2026
Operating expenses totaled $3.614 million in Q2 2026
Cash and cash equivalents reached $492,000 as of June 30, 2026

NEXGEL, Inc. has established itself as a key player in the healthcare sector, focusing on innovative hydrogel technology. The recent revenue growth indicates a positive trend, reflecting the increasing demand for its specialized products. Despite reporting a net loss, the company is actively working to enhance its product offerings and market presence. The financial data suggests a commitment to improving operational efficiency, which may lead to better profitability in the future. Investors may find NEXGEL's unique position in the market and growth potential appealing as the company continues to innovate and expand its product lines.

AI Generated • Aug 25, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Headquarters

Langhorne, PA 19047, US

NXGLW Financials

Key Financial Metrics (TTM)

Gross Margin

35.07%

Operating Margin

-44.77%

Net Income Margin

-51.26%

Return on Equity

-133.10%

Return on Capital

-44.41%

Return on Assets

-23.39%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

Avg. Volume

9.65K

Financials (TTM)

Gross Profit

$4.23M

Operating Income

-$5.40M

EBITDA

-$2.11M

Operating Cash Flow

-$3.21M

Capital Expenditure

-$65.00K

Free Cash Flow

-$3.27M

Cash & ST Invst.

$492.00K

Total Debt

$7.46M

Nexgel Performance Analysis

Nexgel sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	1.7%
Q4	2025-12-31	-4.7%
Q1	2026-03-31	-5.2%
Q2	2026-06-30	39.1%

Nexgel sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	7.9%
Q4	2025-12-31	-50.0%
Q1	2026-03-31	8.3%
Q2	2026-06-30	-263.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$3.69M

+27.8%

Gross Profit

$1.11M

-11.8%

Gross Margin

30.09%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$3.64M

-446.6%

EBITDA

-$398.00K

+23.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$492.00K

-32.1%

Total Debt

$7.46M

+180.9%

Accounts Receivable

$1.08M

+43.3%

Inventory

$2.30M

+26.5%

Long Term Debt

$6.54M

+189.4%

Short Term Debt

$917.00K

+132.2%

Return on Assets

-23.39%

N/A

Return on Invested Capital

-44.99%

N/A

Free Cash Flow

-$2.27M

-432.3%

Operating Cash Flow

-$2.20M

-439.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FEMYFemasys Inc.

FEMYFemasys Inc.$3.43+7.19%

HBIOHarvard Bioscience, Inc.

HBIOHarvard Bioscience, Inc.$8.11+2.27%

CASICASI Pharmaceuticals, Inc.

CASICASI Pharmaceuticals, Inc.$0.15+3.08%

SNYRSynergy CHC Corp.

SNYRSynergy CHC Corp.$0.11+2.13%

COSMCosmos Health Inc.

COSMCosmos Health Inc.$0.24+8.06%

NCNANuCana plc

NCNANuCana plc$1.47-16.48%

PASGPassage Bio, Inc.

PASGPassage Bio, Inc.$4.43-1.99%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About NXGLW

What is the current price of Nexgel?

Nexgel is trading at $0.02 per share.

What is the 52-week range for Nexgel?

Over the past 52 weeks, Nexgel has traded between $0.01 and $0.34.

How much debt does Nexgel have?

Nexgel total debt is unavailable.

How much cash does Nexgel have on hand?

Nexgel does not have cash on hand data available.

What is Nexgel’s dividend yield?

Nexgel does not currently have a dividend yield.

Nexgel(NASDAQ) NXGLW

Nexgel Financials at a Glance

NXGLW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nexgel

NXGLW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nexgel Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NXGLW

What is the current price of Nexgel?

What is the 52-week range for Nexgel?

How much debt does Nexgel have?

How much cash does Nexgel have on hand?

What is Nexgel’s dividend yield?

Premium Investing Services